CAS: 4730-54-5; 1,4,7-Triazacyclononane

该化合物是一种环形三胺化合物,在1,4和7个位置上有一个9个环形环形,有3个氮原子;这一结构具有很强的镀层特性,在协调化学以形成稳定的过渡金属复合体方面很有价值;其僵硬而灵活的环状系统允许有选择性地捆绑,在催化,金属离子分离和生物医学应用方面有用;该化合物的高氮含量还增强了其作为悬浮分子化学中的离心剂的效用. 1,4,7-三亚松纳经常被用作诸如循环衍生物等大型环状的环形项的前体,原因是其高效的合成可及性和金枪鱼的再活性.

结构式图片

相似化合物

58966-93-1 52667-89-7 125262-43-3

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号52667-89-7 1,4,7-三对甲苯磺酰基-1... | CAS号125262-43-3 1,4,7-tribenzyl... | CAS号340970-58-3 N,N',N''-tris(β... | CAS号58966-93-1 1,4,7-三氮环壬烷 三盐酸盐 | CAS号35980-59-7 1,4,7-Triazacyc... | CAS号182306-47-4 1-[(4-ethenylph... | CAS号189033-35-0 1-[[3-(1,4,7-tr... | CAS号96556-05-7 1,4,7-三甲基-1,4,7... | CAS号129820-27-5 [4,7-bis(3,4-di... | CAS号102851-50-3 1,4,7-tris(pyri... | CAS号125262-43-3 1,4,7-tribenzyl... | CAS号112995-08-1 3-[4,7-bis(2-cy... | CAS号71771-37-4 2a,4a,6a-Triaza... | CAS号71771-38-5 2a,4a,6a-Triaza... | CAS号71771-39-6 1,4,7-Triaza-10...

合成工艺路线路线简述

  • 合成目标产物 1,4,7-Triazacyclononane 主要起始原料 1H-1,4,7-Triazonine, Octahydro-1,4,7-Tris(Phenylmethyl)-
  • (文献来源)合成步骤主要原料 1H-1,4,7-Triazonine, Octahydro-1,4,7-Tris(Phenylmethyl)-
N,N',N''-Tris(β-Trimethylsilylethanesulfonyl)-1,4,7-Triazacyclononane置于cesium Fluoride体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应 24.0H,以68%的收率获得产物1,4,7-三氮杂环壬烷
参考文献:通过β-三甲基甲硅烷基乙烷磺酰胺的改性richman-Atkins环化合成聚氮杂大环化合物.
标题:通过β-三甲基甲硅烷基乙烷磺酰胺的改性richman-Atkins环化合成聚氮杂大环化合物.
摘要:Richman-Atkins环化仍然是制备大环多胺的最广泛使用的方法之一.描述了β-三甲基甲硅烷基乙烷磺酰胺(ses-磺酰胺)在制备聚氮杂大环化合物中的用途.这扩展了现有的richman-Atkins磺酰胺大环化方法,并成功地实现了不稳定的聚氮杂[n](1,4)萘甲酸酯和聚氮杂[n](9,10)蒽甲酚的制备,以前没有大量使用.
DOI:10.1021/jo001639O

海关参考信息

专利信息


专利号:WO-2012003598-A1
优先权日:2010-07-06
标 题 :Intermediates for the synthesis of 1,2-bis(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and preparation method thereof
发明人:HAGE RONALD; KOEK JEAN HYPOLITES; RUSSELL STEPHEN WILLIAM; WANG XIAOHONG; WOLF LODEWIJK VAN DER; ZHANG JIANRONG; ZHAO WEI
权利人:UNILEVER PLC; UNILEVER NV; UNILEVER HINDUSTAN; HAGE RONALD; KOEK JEAN HYPOLITES; RUSSELL STEPHEN WILLIAM; WANG XIAOHONG; WOLF LODEWIJK VAN DER; ZHANG JIANRONG; ZHAO WEI
摘要:The present invention provides intermediates for the synthesis of 1,2-bis(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and preparation method thereof. The intermediates are protonated salts of 1,4-ditosylate-1,4,7-triazacyclononane or 1,4-dibenzenesulphonate-1,4,7-triazacyclononane. The preparation method of 1,4-diarylsulfonate-1,4,7-triazacyclononane (compound A) comprises reacting 1,4,7-triarylsulfonate-1,4,7-triazacyclononane (compound B) in an acidic medium comprising sulphuric acid, wherein the molar ratio of B to sulphuric acid is in the range from 1 : 0.5 to 1 : 10, or reacting 1,4,7-triarylsulfonate-1,4,7-triazacyclononane (compound B) in an acidic medium and working up the acidic medium when the conversion of B to A is at least 50 mol % yielding compound A.

专利号:US-8907082-B2
优先权日:2010-07-06
标 题 :1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate for the synthesis of same
发明人:HAGE RONALD; KOEK JEAN HYPOLITES; RUSSELL STEPHEN WILLIAM; VAN DER WOLF LODEWIJK; ZHANG JIANRONG; ZHAO WEI; WANG XIAOHONG
权利人:HAGE RONALD; KOEK JEAN HYPOLITES; RUSSELL STEPHEN WILLIAM; VAN DER WOLF LODEWIJK; ZHANG JIANRONG; ZHAO WEI; WANG XIAOHONG; CATEXEL LTD
摘要:The present invention provides improved processes for the synthesis of 1,4-ditosyl-1,4,7-triazacyclonone, comprising deprotecting a compound of formula (C): n nwherein P is tosylate or arylsulfonate, with an acidic medium to form 1,2-bis(1,4,7-triazacyclonon-1-yl)-ethane; and subsequently adding formaldehyde and formic acid to the acidic medium to form 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane (Me 4 -DTNE). The syntheses of intermediates are also disclosed.

专利号:US-9988388-B2
优先权日:2012-11-21
标 题:Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C- functionalized derivatives thereof
发明人:DENAT FRANCK; DESOGERE PAULINE; BERNHARD CLAIRE; ROUSSELIN YOANN; BOSCHETTI FREDERIC
权利人:UNIV BOURGOGNE; CENTRE NAT RECH SCIENT
摘要:A compound with formula (V′) n nthe synthesis method for compound (V′), and its use for the preparation of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof, particularly compounds with formula (I)n n nAlso, metallic complexes comprising a ligand with formula (I) and a metal and their use for imaging.

专利号:WO-2025088147-A1
优先权日:2023-10-27
标题 :Theranostic psma-targeting ligands for the diagnosis and treatment of psma-expressing cancers and their solid phase synthesis
发明人:Schäfer Martin; BAUDER-WUEST ULRIKE; ROSCHER MAREIKE; REMDE YVONNE; BENEÅ OVà -SCHÄFER MARTINA; BARINKA CYRIL; KUTILOVà ZSÓFIA; MOTLOVà LUCIA
权利人:DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS
摘要:The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and radiopharmaceuticals for the treatment of various disease states of PSMA-expressing cancers, especially prostate cancer, and metastases thereof. Further the present invention provides synthetic procedures for the synthesis of such PSMA-targeting ligands.

专利号:US-2025049714-A1
优先权日:2021-12-09
标题 :Synthesis of ester, carbonate, and carbamate-derived novel biodegradable ionizable lipids from methyl ricinoleate or methyl 12-hydroxystearate and its applications
发明人:ANDERSON DANIEL GRIFFITH; RHYM LUKE HYUNSIK; LI BOWEN; GORDON AKIVA; RAJITH SINGH MANAN; WITTEN JACOB
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).

专利号:US-2025313580-A1
优先权日:2022-05-19
标题 :Synthesis of fluorosilyl compounds
发明人:FORD THONAN LEE; THOMAS ALEXANDER JAMES FLOY; RAHMAN SABITUR
权利人:BLUE EARTH THERAPEUTICS LTD
摘要:The disclosures herein relate to methods of synthesising a compound of formula (1): n n n n n n n n n n wherein PG, R 2 and R 3 are as defined herein, and the use of said methods in the manufacture of conjugates that bind to PSMA.
江西伯业医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.boyepharm.com
企业联系电话:18971341812(同微信);QQ1564214480👤
📞江西伯业医药科技有限公司 ⚠️参考联系方式
联系人:徐双凤
电话:18971341812(同微信);QQ1564214480
手机:18971341812(同微信);QQ1564214480

邮箱:1973211433@qq.com
通信地址: 江西省新余市渝水区解放东路19号
邮编: 430000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江西省新余市渝水区解放东路19号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Guo Jf, Et, Al. Trans-[参考文献]: Nonat A, Et, Al. Structural And Photophysical Studies Of Highly Stable Lanthanide Complexes Of Tripodal 8-Hydroxyquinolinate Ligands Based On 1,4,7-Triazacyclononane. Inorg Chem. 2009 May 4;48(9):4207-18.

合成参考文献


参考文献:10.1021/ol010256p|10.1021/ol016291d
摘要:Warden A, Graham B, Hearn MT, Spiccia L. Synthesis of novel derivatives of 1,4,7-triazacyclononane. Org Lett. 2001 Sep 06;3(18):2855–8. doi: 10.1021/ol016291d.
参考文献:10.1002/chem.200501390
摘要:Nonat A, Gateau C, Fries PH, Mazzanti M. Lanthanide complexes of a picolinate ligand derived from 1,4,7-triazacyclononane with potential application in magnetic resonance imaging and time-resolved luminescence imaging. Chemistry. 2006 Sep 18;12(27):7133–50. doi: 10.1002/chem.200501390.
参考文献:10.1007/s10787-007-0018-5
摘要:Tiekink ER. Anti-cancer potential of gold complexes. Inflammopharmacology. 2008 Jun;16(3):138–42. doi: 10.1007/s10787-007-0018-5.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知